Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
The Epilepsy Foundation is warning people who take Dilantin or Lamictal to control their seizures that the medications can cause users to suffer from a rare but serious skin condition known as Stevens Johnson Syndrome (SJS).
On September 21, 2008, Kendra Schmidt was pushed in a wheelchair through the track of the Fox Cities Marathon. “My sister ran it that year and my husband (Mike) pushed me,” she told the Post Crescent. But Kendra was determined. “I knew I’d run in it eventually.”
Famotidine, the heartburn drug most known by the brand name Pepcid, is yet another drug that has been linked to a deadly skin reaction known as toxic epidermal necrolysis (TEN), the most serious version of Stevens Johnson Syndrome (SJS). Famotidine is available by both prescription and over-the-counter in either a tablet or suspension (liquid) that is taken by mouth. It is in a class of medications called H2 blockers and works by decreasing the amount of acid made in the stomach. Famotidine is used to treat ulcers, gastroesophageal reflux disease (GERD), and conditions where the stomach produces too much acid.
The passing of former NBA star Manute Bol from an allergic reaction to medication has promoted many people to ask, What is Stevens Johnson Syndrome (SJS) and who is at risk? The answers, unfortunately, are not always clear. SJS is a serious skin and mucous membrane condition that has been associated with thousands of medications, both over-the-counter and prescriptions. The most common ones linked to SJS include some of the most widely used medications – ibuprofen and antibiotics. Others on the list are anti-viral and anti-seizure drugs.
Eva Uhlin was 15 when a capsule of acetaminophen (sold over-the-counter as Tylenol) caused her face to “turn black and fall off,” according to Natural News. The young woman experienced a serious allergic reaction to the medication called toxic epidermal necrolysis (TEN), the most severe form of the skin condition Stevens Johnson Syndrome (SJS).
A medication approved by the Food and Drug Administration (FDA) to treat migraine headaches is scheduled to become available in the United States this month. Cambia (diclofenac potassium for oral solution) was found to reduce migraine pain within 30 minutes, according to a study published in Cephalalgia, the international journal of headache.
A newly approved drug for the treatment of arthritis in patients at risk of developing NSAID-associated gastric ulcers has been linked to a rare but serious hypersensitivity disorder known as Stevens Johnson Syndrome (SJS).
A medicine used to treat and help prevent the flu may put patients at risk for a rare but life-threatening condition in which the skin peels off the body in sheets, according to the Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research. The agency notified the public that it has approved safety label changes for Relenza (zanamivir) Inhalation Powder for oral inhalation. The Adverse Reactions section of the drug’s new safety label now includes a risk of rash, including serious cutaneous reactions (e.g. erythema multiforme, Stevens Johnson Syndrome, SJS, and toxic epidermal necrolysis, TEN).
A medication used for the management of hypertension now includes an updated safety label that warns patients of a rare but serious skin condition, according to the Food and Drug Administration (FDA)’s Safety Information and Adverse Event Reporting Program. The new safety label for Inderide (propranolol HCL/hydrochlorothiazide) tablets carries a warning of “erythema multiforme including Stevens Johnson Syndrome (SJS), exfoliative dermatitis, including toxic epidermal necrolysis (TEN)” in the Adverse Reactions section.
A drug used to treat acid reflux disease has been linked to a rare but serious skin condition known as Stevens Johnson Syndrome (SJS) and its more severe form, toxic epidermal necrolysis (TEN), according to the Food and Drug Administration (FDA). Dexilant (dexlansoprazole) delayed release capsules now includes a warning of the risk of SJS and TEN in the Adverse Reactions section of its safety label. The updated label states that in post-marketing review, some patients taking Dexilant suffered immune system disorders including anaphylactic shock that required emergency intervention, and SJS and TEN. Some cases were fatal.
![[ Beasley Allen Law Firm Logo ]](http://www.sjs-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}